SCHEMBL14083898

SCHEMBL14083898

CCOc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 9/20 0.70
▸ NPC1 O15118 5/20 0.66
▸ RAB9A P51151 5/20 0.66
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ KDM4E B2RXH2 2/20 0.62
▸ MITF O75030 1/20 0.62
▸ PKM P14618 1/20 0.62
▸ LMNA P02545 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ TP53 P04637 1/20 0.57
▸ XDH P47989 1/20 0.56
▸ PPARG P37231 1/20 0.56
▸ RXFP1 Q9HBX9 1/20 0.56
▸ NCOR2 Q9Y618 1/20 0.56
▸ TRPV4 Q9HBA0 1/20 0.56
▸ MAPT P10636 2/20 0.55
▸ GAA P10253 1/20 0.55
▸ POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083887 0.91 TRPV1 (0.67) TRPV1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL14083861 0.89 TRPV1 (0.70) TRPV1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL3882995 0.88 TRPV1 (0.73) TRPV1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL14083920 0.88 TRPV1 (0.60) TRPV1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL14084033 0.88 NPC1 (0.61) TRPV1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL3874198 0.86 TRPV1 (0.73) TRPV1NPC1RAB9ASMN1; SMN2TRPV4
SCHEMBL14083862 0.86 RAB9A (0.65) TRPV1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL3874648 0.85 TRPV1 (0.68) TRPV1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL14083879 0.84 TRPV1 (0.78) TRPV1TRPV4
SCHEMBL3872091 0.84 TRPV1 (0.78) TRPV1NPC1RAB9ASMN1; SMN2TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885NPC1 1061/4885RAB9A 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback